A mechanistic look at the effects of adversity early in life on cardiovascular disease risk during adulthood

od Loria, A. S., Ho, D. H., Pollock, J. S.
Wydane 2013

Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer.

od Rolston, K V, Messer, M, Ho, D H
Wydane 1990

Comparison of vancomycin disposition in rats with normal and abnormal renal functions.

od Engineer, M S, Ho, D H, Bodey, G P
Wydane 1981

In vitro studies of BMY-28142, a new broad-spectrum cephalosporin.

od Bodey, G P, Ho, D H, LeBlanc, B
Wydane 1985

Clinical pharmacology of moxalactam in patients with malignant disease.

od Estey, E H, Weaver, S S, Ho, D H, Bodey, G P
Wydane 1981

In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.

od Rolston, K V, Ho, D H, LeBlanc, B, Bodey, G P
Wydane 1987

In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer.

od Rolston, K V, LeBlanc, B, Ho, D H, Bodey, G P
Wydane 1987

In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.

od Rolston, K V, Ho, D H, LeBlanc, B, Bodey, G P
Wydane 1993

In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients.

od Garcia, I, Bodey, G P, Fainstein, V, Ho, D H, LeBlanc, B
Wydane 1984

In vitro susceptibility of Citrobacter species to various antimicrobial agents.

od Samonis, G, Ho, D H, Gooch, G F, Rolston, K V, Bodey, G P
Wydane 1987

In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.

od Rolston, K V, Nguyen, H T, Ho, D H, LeBlanc, B, Bodey, G P
Wydane 1992

Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.

od Dholakia, N, Rolston, K V, Ho, D H, LeBlanc, B, Bodey, G P
Wydane 1994

Pharmacokinetics of cefoperazone in patients with neoplastic disease.

od Maksymiuk, A W, LeBlanc, B M, Brown, N S, Ho, D H, Bodey, G P
Wydane 1981

In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.

od Rolston, K V, Nguyen, H, Messer, M, LeBlanc, B, Ho, D H, Bodey, G P
Wydane 1990

Clinical pharmacokinetics of aztreonam in cancer patients.

od Jones, P G, Bodey, G P, Swabb, E A, Ho, D H, Fainstein, V, Pasternak, J
Wydane 1984

In vitro activity of BRL 36650, a new semisynthetic penicillin.

od Hoy, J F, Rolston, K V, Ho, D H, Alvarez, M, Thirolf, P, Bodey, G P
Wydane 1986

Sensitive radioimmunoassay for vancomycin.

od Fong, K L, Ho, D H, Bogerd, L, Pan, T, Brown, N S, Gentry, L, Bodey, G P
Wydane 1981

Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.

od Reuben, A, Anaissie, E, Nelson, P E, Hashem, R, Legrand, C, Ho, D H, Bodey, G P
Wydane 1989

Effects of hepatic function on vancomycin clinical pharmacology.

od Brown, N, Ho, D H, Fong, K L, Bogerd, L, Maksymiuk, A, Bolivar, R, Fainstein, V, Bodey, G P
Wydane 1983